Cita APA

Valencia, G., Rioja, P., Morante, Z., Araujo, J., Vallejos, H., Guerra, H., & Gomez, H. L. (2021). PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report.

Citación estilo Chicago

Valencia, GA, P. Rioja, Z. Morante, JM Araujo, HD Vallejos, H. Guerra, y Henry L. Gomez. PIK3CA Mutation in Non-metastatic Triple-negative Breast Cancer As a Potential Biomarker of Early Relapse: A Case Report. 2021.

Cita MLA

Valencia, GA, et al. PIK3CA Mutation in Non-metastatic Triple-negative Breast Cancer As a Potential Biomarker of Early Relapse: A Case Report. 2021.